RCP 110: Patient Monitoring

Principles of Patient Monitoring

• Definition of Monitoring: Patient monitoring involves repeatedly or continuously observing patient data over a period of time to track clinical status and physiologic variables.
• Monitor Functionality and Limitations: A monitor serves exclusively as an information tool to deliver continuous or periodic quantitative metrics; it does not replace direct physical observation and clinical assessment of the patient.
• Focus on Longitudinal Trends: Clinical interpretation must prioritize trend analysis over isolated numbers to establish whether a patient's condition is stable, improving, or worsening over time.
• Management of Sudden Value Changes:
  • Immediately perform a direct bedside clinical assessment of the patient.
  • Inspect equipment connections, signal integrity, sensor alignment, and hardware functionality.
  • Confirm unexpected or abnormal findings using secondary diagnostic tests or direct laboratory measurements when clinically appropriate.

Capnography and Exhaled Carbon Dioxide Monitoring

• Target Parameters: Capnography continuously measures exhaled carbon dioxide levels, designated as exhaled carbon dioxide ($\text{ECO}_2$), end-tidal carbon dioxide ($\text{ETCO}_2$), or partial pressure of end-tidal carbon dioxide ($\text{P}_{\text{etCO}_2}$).
• Measurement Mechanism: Operates via noninvasive infrared absorption spectroscopy.
• Determinants of Exhaled Carbon Dioxide: Under normal physiologic conditions, $\text{ETCO}_2$ levels fluctuate based on three main systems:
  • Ventilation (clearance of $\text{CO}_2$ from the lungs).
  • Circulation and Perfusion (delivery of $\text{CO}_2$ via pulmonary blood flow).
  • Metabolism (cellular production of $\text{CO}_2$).
• Diagnostic Interpretation of Variations:
  • Rising $\text{ETCO}_2$ Levels: Associated with hypoventilation (decreased alveolar ventilation leading to $\text{CO}_2$ retention).
  • Falling $\text{ETCO}_2$ Levels: Associated with hyperventilation (excessive clearance) or reduced pulmonary blood flow (such as acute pulmonary embolism).
  • Sudden Unexpected Drops or Artifacts: May indicate acute airway compromise, circuit disconnects, sample line obstruction, or equipment malfunction.
• Applications in Cardiopulmonary Resuscitation (CPR):
  • Monitor chest compression effectiveness during active CPR, where $\text{ETCO}_2$ values reflect generated cardiac output.
  • Detect Return of Spontaneous Circulation (ROSC): Initial $\text{ETCO}_2$ readings during cardiac arrest are characteristically low; a sudden, sustained rise in $\text{ETCO}_2$ indicates ROSC.

Noninvasive Pulse Oximetry

• Primary Clinical Utility: Pulse oximetry is the standard, most appropriate noninvasive technique for continuous real-time monitoring of arterial oxygen saturation ($\text{SpO}_2$) and pulse rate.
• Mechanism of Action: Probe containing light emitters attaches to a peripheral capillary bed (such as a finger) and transmits light pulses through tissue to measure differential light absorption by oxygenated and deoxygenated hemoglobin.
• Diagnostic Indications:
  • Continuous monitoring during sleep studies.
  • Evaluation of baseline resting oxygen saturation levels.
  • Assessment of exercise-induced desaturation during stress testing or exertion protocols.
• Factors Impairing Accuracy: High signal quality and robust peripheral perfusion are required for maximal accuracy. Accuracy drops significantly at very low saturation thresholds. Confounding factors include:
  • Skin pigmentation variations.
  • Nail polish or artificial products on nails.
  • Patient motion artifacts.
  • Intense ambient light exposure.
  • Poor peripheral perfusion states (e.g., systemic shock, severe hypotension).
  • Tissue conditions interfering with light transmission (e.g., severe erythema).
• Limitation in Carbon Monoxide Exposure: Standard pulse oximeters cannot distinguish carboxyhemoglobin ($\text{COHb}$) from oxyhemoglobin ($\text{O}_2\text{Hb}$). In the presence of carbon monoxide poisoning, the $\text{SpO}_2$ reads falsely elevated and is entirely inaccurate for evaluating actual oxygenation status.
• Quality Control and Troubleshooting Protocol:
  • Calibration is pre-set by the manufacturer.
  • When sudden drops in $\text{SpO}_2$ occur alongside changes in clinical status, investigate potential probe malfunction: reattach or replace the sensor probe, or re-site the probe on an alternative peripheral capillary bed.
  • Reconfirm unexpected or extremely low $\text{SpO}_2$ values using arterial blood gas (ABG) co-oximetry measurements when clinically indicated.
  • Never delay direct patient assessment or resuscitation while troubleshooting equipment or questionable oximetry signals.

Overnight Oximetry and Sleep Assessment

• Definition and Purpose: Noninvasive, continuous evaluation of arterial oxygen saturation over an extended overnight rest period.
• Clinical Indications:
  • Screening protocol for identifying sleep-related breathing disorders.
  • Assessing patient response to therapeutic interventions for obstructive sleep apnea (OSA), such as positive airway pressure therapy.
• Technical Requirements:
  • High-quality, portable monitoring hardware capable of continuous recording of oxyhemoglobin saturation and pulse rate.
  • Device recording parameters must be configured to the shortest available measurement sampling interval.
• Data Analysis Criteria:
  • Identify and quantify all nocturnal desaturation events defined as $\text{SpO}_2 < 89\%$ .
  • Note significant downward deviations or fluctuations relative to baseline resting values.
• Therapeutic Recommendation: If nocturnal desaturation events ($< 89\%$) are detected during overnight oximetry screening, formal polysomnography (full sleep study) is indicated for comprehensive diagnostic evaluation.

Invasive Hemoximetry and Co-Oximetry

• Diagnostic Purpose: Co-oximetry (hemoximetry) is the definitive gold standard diagnostic modality for identifying and quantifying carbon monoxide poisoning and non-functional hemoglobin species.
• Reference Ranges and Clinical Thresholds:
  • Normal baseline carboxyhemoglobin ($\text{COHb}$): $0\%\text{--}1\%$ .
  • Expected $\text{COHb}$ range for active cigarette smokers: $2\%\text{--}12\%$ .
  • Diagnostic threshold for Carbon Monoxide Poisoning: $\text{COHb} > 20\%$ .
• Technical Mechanism:
  • Requires an invasive blood sample rather than a noninvasive skin sensor.
  • Uses spectrophotometry with multiple specific wavelengths of light to directly differentiate between oxyhemoglobin ($\text{O}_2\text{Hb}$), carboxyhemoglobin ($\text{COHb}$), methemoglobin ($\text{MetHb}$), and reduced hemoglobin.
• Clinical Value: Provides precise, non-continuous measurement of oxygenation and dysfunctional hemoglobin states that standard noninvasive pulse oximeters misidentify.

Transcutaneous Oxygen and Carbon Dioxide Monitoring

• Underlying Principles: Utilizes modified Clark oxygen ($\text{O}_2$) electrodes and Severinghaus carbon dioxide ($\text{CO}_2$) electrodes applied directly to the skin surface to provide continuous noninvasive partial pressure measurements ($\text{TcP}_{\text{O}_2}$ and $\text{TcP}_{\text{CO}_2}$), replacing repetitive discrete arterial blood sampling.
• Physiological Mechanism and Temperature Controls:
  • Surface electrodes contain heating elements maintained at $43\,^\circ\text{C}\text{--}45\,^\circ\text{C}$ .
  • Heating dilates local cutaneous capillary beds, accelerating blood flow (perfusion) and increasing gas diffusion through skin layers toward the sensor.
• Factors Influencing Accuracy:
  • Transcutaneous readings correlate strongly with arterial blood gas tensions ($\text{P}_{\text{aO}_2}$ and $\text{P}_{\text{aCO}_2}$) provided peripheral tissue perfusion remains adequate.
  • Correlation degrades in conditions with increased skin thickness, severe anemia, or hypoperfusion states (e.g., clinical shock, systemic dehydration, severe burns, peripheral vascular disease, cardiac malformations).
• Sensor Site Placement and Rotation Protocols:
  • Placement must occur over flat, highly perfused skin areas, routinely on the upper chest wall beneath the center of the right or left clavicle.
  • Sensor sites must be rotated every $4\,\text{hours}$ to prevent thermal skin injury.
  • Increase site rotation frequency if localized redness, erythema, or blistering occurs.
• Calibration and Quality Control Standards:
  • $\text{P}_{\text{O}_2}$ Electrode Calibration: High-point calibration uses ambient room air ($\text{P}_{\text{O}_2} = 150\,\text{torr}$); low-point calibration uses electronic zeroing.
  • $\text{P}_{\text{CO}_2}$ Electrode Calibration: High-point calibration uses a $10\%\,\text{CO}_2$ gas mixture; low-point calibration uses a $5\%\,\text{CO}_2$ gas mixture.
  • Calibration Schedule: Perform calibration prior to initial clinical application and every time the electrode is removed and repositioned.
  • Laboratory Cross-Validation: Direct arterial blood gas values must be drawn and compared against transcutaneous readings obtained simultaneously.
  • Technical Troubleshooting: Inspect for torn hydrophobic membranes or loose wiring connections if calibration fails.
  • Air Leak Artifacts: Unsealed contact between the electrode and skin allows atmospheric air contamination, causing $\text{TcP}_{\text{O}_2}$ readings to read falsely elevated relative to actual $\text{P}_{\text{aO}_2}$.

Critical Care and Hemodynamic Monitoring

• Multimodal Critical Care Assessment: Critically ill patients require simultaneous, continuous monitoring across multiple physiologic parameters:
  • Heart rate and cardiac rhythm.
  • Noninvasive and invasive systemic blood pressure.
  • Respiratory rate and pattern.
  • Oxygen saturation ($\text{SpO}_2$) and end-tidal carbon dioxide ($\text{ETCO}_2$).
  • Core body temperature.
  • Urine output and hourly fluid balance.
  • Neurologic status and scoring systems.
  • Invasive hemodynamic pressures or intracranial pressure (ICP) when clinically indicated.
• Role of Respiratory Therapy: Integrating continuous monitoring data into comprehensive respiratory physical assessments to detect early systemic deterioration, evaluate therapeutic responsiveness, and escalate clinical management.
• Fundamentals of Hemodynamics:
  • Refers to blood circulation mechanics and driving pressure gradients throughout the cardiovascular system.
  • Core variables include heart rate, systemic blood pressure, and mean arterial pressure (MAP).
  • Hemodynamic fluctuations directly alter microvascular tissue perfusion and global oxygen delivery ($\text{D}_{\text{O}_2}$).
• Fluid Balance Assessment: Fluid intake, fluid output, peripheral/pulmonary edema, and hourly urine output serve as vital surrogates for assessing circulatory volume status and end-organ perfusion.

Mechanical Ventilator Monitoring

• Scope of Mechanical Ventilator Monitoring: Maintenance of invasive mechanical ventilation demands continuous simultaneous monitoring of both patient pulmonary responses and ventilator performance parameters.
• Essential Monitored Variables:
  • Airway pressures (peak inspiratory pressure, plateau pressure, mean airway pressure).
  • Tidal volume ($\text{V}_{\text{T}}$) and minute ventilation ($\text{V}_{\text{E}}$).
  • Total respiratory rate ($\text{f}$) and inspiratory/expiratory timing.
  • Inspiratory gas flow rates and flow waveforms.
  • Fraction of inspired oxygen ($\text{F}_{\text{iO}_2}$).
  • Positive end-expiratory pressure (PEEP).
• Evaluation of Pulmonary Mechanics: Real-time analysis of airway pressure, volume, and flow curves identifies lung compliance changes, airway resistance changes, and patient-ventilator dyssynchrony.
• Safety Protocols: Continuously track trends and maintain ventilator safety alarm thresholds. Always disconnect the patient and provide manual ventilation while prioritizing patient assessment whenever acute alarm triggers or ventilator dysfunctions occur.
• Artificial Airway Management: Monitor endotracheal or tracheostomy tube cuff pressures regularly to preserve an adequate circuit seal while maintaining pressures below mucosal capillary perfusion thresholds to prevent tracheal ischemia and injury.

Hand-Off Communication and SBAR Simulation

• Hand-Off Methodology: SBAR structured verbal communication framework covering Situation, Background, Assessment, and Recommendation.
• Sequential Information Transfer Protocol:
  • Verbal shift hand-off report passed sequentially from clinician to clinician in a chain (Participant #1 to Participant #2, Participant #2 to Participant #3, continuing through the entire cohort).
  • Final participant delivers the cumulative SBAR hand-off report aloud to the entire team.
• Simulation Rules:
  • No written note-taking permitted.
  • No viewing of written original clinical data allowed.
  • No overhearing prior transfers in the chain allowed.
  • Re-contacting previous senders for forgotten information is strictly prohibited.
  • Single-exposure rule: Each receiving clinician hears the report exactly once.
  • Clarification rule: A receiving clinician may ask exactly one clarification question to the immediate sender during hand-off.
• Clinical Quality Debrief Metrics: Group analysis comparing the initial clinical report against the final transmitted report to evaluate:
  • Accurate retention of clinical details.
  • Omitted or lost critical physiological data.
  • Distortions or alterations of facts during transfer.
  • Fabrication or insertion of unstated details.
  • Potential impacts on patient safety and subsequent clinical respiratory therapy decision-making.